Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Neurofilaments and neurological disease.

Al-Chalabi A, Miller CC.

Bioessays. 2003 Apr;25(4):346-55. Review.

PMID:
12655642
2.

Neurofilaments in health and disease.

Julien JP, Mushynski WE.

Prog Nucleic Acid Res Mol Biol. 1998;61:1-23. Review.

PMID:
9752717
3.

Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review.

Rao MV, Nixon RA.

Neurochem Res. 2003 Jul;28(7):1041-7. Review.

PMID:
12737529
4.

New movements in neurofilament transport, turnover and disease.

Barry DM, Millecamps S, Julien JP, Garcia ML.

Exp Cell Res. 2007 Jun 10;313(10):2110-20. Review.

PMID:
17451679
5.

Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport.

Brownlees J, Ackerley S, Grierson AJ, Jacobsen NJ, Shea K, Anderton BH, Leigh PN, Shaw CE, Miller CC.

Hum Mol Genet. 2002 Nov 1;11(23):2837-44.

6.

Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth Type 2E phenotype.

Adebola AA, Di Castri T, He CZ, Salvatierra LA, Zhao J, Brown K, Lin CS, Worman HJ, Liem RK.

Hum Mol Genet. 2015 Apr 15;24(8):2163-74. doi: 10.1093/hmg/ddu736.

7.
8.

Deregulation of PKN1 activity disrupts neurofilament organisation and axonal transport.

Manser C, Stevenson A, Banner S, Davies J, Tudor EL, Ono Y, Leigh PN, McLoughlin DM, Shaw CE, Miller CC.

FEBS Lett. 2008 Jun 25;582(15):2303-8. doi: 10.1016/j.febslet.2008.05.034.

9.

Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Perrot R, Berges R, Bocquet A, Eyer J.

Mol Neurobiol. 2008 Aug;38(1):27-65. doi: 10.1007/s12035-008-8033-0. Review.

PMID:
18649148
10.
11.

Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis.

Menzies FM, Grierson AJ, Cookson MR, Heath PR, Tomkins J, Figlewicz DA, Ince PG, Shaw PJ.

J Neurochem. 2002 Sep;82(5):1118-28.

12.

The amount of neurofilaments aggregated in the cell body is controlled by their increased sensitivity to trypsin-like proteases.

Fasani F, Bocquet A, Robert P, Peterson A, Eyer J.

J Cell Sci. 2004 Feb 29;117(Pt 6):861-9.

13.

Neurofilament dynamics and involvement in neurological disorders.

Gentil BJ, Tibshirani M, Durham HD.

Cell Tissue Res. 2015 Jun;360(3):609-20. doi: 10.1007/s00441-014-2082-7. Review.

PMID:
25567110
14.

Slow component of axonal transport is impaired in the proximal axon of transgenic mice with a G93A mutant SOD1 gene.

Sasaki S, Warita H, Abe K, Iwata M.

Acta Neuropathol. 2004 May;107(5):452-60.

PMID:
15029446
15.
16.

Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.

Williamson TL, Bruijn LI, Zhu Q, Anderson KL, Anderson SD, Julien JP, Cleveland DW.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9631-6.

17.

Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport.

Marszalek JR, Williamson TL, Lee MK, Xu Z, Hoffman PN, Becher MW, Crawford TO, Cleveland DW.

J Cell Biol. 1996 Nov;135(3):711-24.

18.

Neurofilament function and dysfunction: involvement in axonal growth and neuronal disease.

Lee MK, Cleveland DW.

Curr Opin Cell Biol. 1994 Feb;6(1):34-40. Review.

PMID:
7513179
19.

Extra axonal neurofilaments do not exacerbate disease caused by mutant Cu,Zn superoxide dismutase.

Couillard-Despr├ęs S, Meier J, Julien JP.

Neurobiol Dis. 2000 Aug;7(4):462-70.

PMID:
10964615
Items per page

Supplemental Content

Support Center